-
Fund Dashboard
- Holdings
EQ/T.Rowe Price Health Sciences Portfolio
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 19.77 mm | 22.31 k shares | 10.47 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 13.78 mm | 23.56 k shares | 7.30 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 9.51 mm | 15.38 k shares | 5.04 | Common equity | Long | USA |
ISRG Intuitive Surgical, Inc. | 9.01 mm | 18.34 k shares | 4.77 | Common equity | Long | USA |
DHR Danaher Corporation | 7.61 mm | 27.38 k shares | 4.03 | Common equity | Long | USA |
SYK Stryker Corporation | 6.82 mm | 18.88 k shares | 3.61 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 5.83 mm | 51.33 k shares | 3.09 | Common equity | Long | USA |
ELV Elevance Health Inc. | 5.62 mm | 10.82 k shares | 2.98 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 5.54 mm | 5.27 k shares | 2.94 | Common equity | Long | USA |
ARGX argenx SE | 5.36 mm | 9.90 k shares | 2.84 | Common equity | Long | Netherlands |
VRTX Vertex Pharmaceuticals Incorporated | 4.55 mm | 9.79 k shares | 2.41 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 4.49 mm | 16.33 k shares | 2.38 | Common equity | Long | USA |
AMGN Amgen Inc. | 4.17 mm | 12.93 k shares | 2.21 | Common equity | Long | USA |
AstraZeneca plc
|
3.88 mm | 49.85 k shares | 2.06 | Common equity | Long | UK |
Cigna Holding Co | 3.31 mm | 9.57 k shares | 1.76 | Common equity | Long | USA |
BSX Boston Scientific Corporation | 3.19 mm | 38.02 k shares | 1.69 | Common equity | Long | USA |
INSM Insmed Incorporated | 2.34 mm | 32.10 k shares | 1.24 | Common equity | Long | USA |
HCA HCA Healthcare, Inc. | 2.24 mm | 5.51 k shares | 1.19 | Common equity | Long | USA |
MOH Molina Healthcare, Inc. | 2.15 mm | 6.24 k shares | 1.14 | Common equity | Long | USA |
BDX Becton, Dickinson and Company | 2.12 mm | 8.78 k shares | 1.12 | Common equity | Long | USA |
NVO Novo Nordisk A/S | 2.10 mm | 17.63 k shares | 1.11 | Common equity | Long | Denmark |
ONC BeiGene, Ltd. | 2.01 mm | 8.97 k shares | 1.07 | Common equity | Long | Cayman Islands |
DREYFUS TREASURY OBLIGATIONS CASH MANAGEMENT FUND OPEN-END FUND USD | 2.00 mm | 2.00 mm principal | 1.06 | Short-term investment vehicle | Long | USA |
THC Tenet Healthcare Corporation | 1.77 mm | 10.64 k shares | 0.94 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 1.65 mm | 17.81 k shares | 0.87 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 1.65 mm | 11.02 k shares | 0.87 | Common equity | Long | Denmark |
PCVX Vaxcyte, Inc. | 1.63 mm | 14.26 k shares | 0.86 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 1.54 mm | 33.62 k shares | 0.82 | Common equity | Long | USA |
PEN Penumbra, Inc. | 1.50 mm | 7.72 k shares | 0.80 | Common equity | Long | USA |
A Agilent Technologies, Inc. | 1.31 mm | 8.82 k shares | 0.69 | Common equity | Long | USA |
Biohaven Ltd.
|
1.14 mm | 22.87 k shares | 0.61 | Common equity | Long | Virgin Islands (British) |
UTHR United Therapeutics Corporation | 1.04 mm | 2.92 k shares | 0.55 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 1.00 mm | 14.74 k shares | 0.53 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 990.43 k | 8.60 k shares | 0.52 | Common equity | Long | USA |
INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD | 983.75 k | 983.75 k principal | 0.52 | Short-term investment vehicle | Long | USA |
SNY Sanofi | 949.51 k | 16.48 k shares | 0.50 | Common equity | Long | France |
Chugai Pharmaceutical Co. Ltd.
|
901.92 k | 18.70 k shares | 0.48 | Common equity | Long | Japan |
RVMD Revolution Medicines, Inc. | 893.53 k | 19.70 k shares | 0.47 | Common equity | Long | USA |
EW Edwards Lifesciences Corporation | 888.36 k | 13.46 k shares | 0.47 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 875.96 k | 40.00 k shares | 0.46 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 819.36 k | 10.25 k shares | 0.43 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics | 812.11 k | 16.11 k shares | 0.43 | Common equity | Long | Cayman Islands |
HOLX Hologic, Inc. | 808.73 k | 9.93 k shares | 0.43 | Common equity | Long | USA |
ICON plc
|
782.63 k | 2.72 k shares | 0.41 | Common equity | Long | Ireland |
KYMR Kymera Therapeutics, Inc. | 775.79 k | 16.39 k shares | 0.41 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 773.04 k | 17.40 k shares | 0.41 | Common equity | Long | USA |
OSCR Oscar Health, Inc. | 769.84 k | 36.30 k shares | 0.41 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 767.62 k | 9.19 k shares | 0.41 | Common equity | Long | USA |
Sonova Holding AG (Registered)
|
764.93 k | 2.13 k shares | 0.41 | Common equity | Long | Switzerland |
HUM Humana Inc. | 718.37 k | 2.27 k shares | 0.38 | Common equity | Long | USA |
IDXX IDEXX Laboratories, Inc. | 716.91 k | 1.42 k shares | 0.38 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 704.41 k | 13.79 k shares | 0.37 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 702.87 k | 12.65 k shares | 0.37 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 697.65 k | 13.21 k shares | 0.37 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 680.50 k | 16.99 k shares | 0.36 | Common equity | Long | USA |
RVTY Revvity, Inc. | 674.65 k | 5.28 k shares | 0.36 | Common equity | Long | USA |
Madrigal Pharmaceuticals, Inc. | 665.10 k | 3.13 k shares | 0.35 | Common equity | Long | USA |
NTRA Natera, Inc. | 647.45 k | 5.10 k shares | 0.34 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 625.38 k | 39.11 k shares | 0.33 | Common equity | Long | UK |
GPCR Structure Therapeutics Inc. | 622.76 k | 14.19 k shares | 0.33 | Common equity | Long | Cayman Islands |
DNLI Denali Therapeutics Inc. | 579.83 k | 19.91 k shares | 0.31 | Common equity | Long | USA |
MCK McKesson Corporation | 574.02 k | 1.16 k shares | 0.30 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 544.50 k | 12.10 k shares | 0.29 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 530.84 k | 12.01 k shares | 0.28 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 528.43 k | 2.90 k shares | 0.28 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals, Inc. | 523.21 k | 15.70 k shares | 0.28 | Common equity | Long | USA |
RGEN Repligen Corporation | 519.83 k | 3.49 k shares | 0.28 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 511.71 k | 16.44 k shares | 0.27 | Common equity | Long | UK |
CAH Cardinal Health, Inc. | 511.04 k | 4.62 k shares | 0.27 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 508.06 k | 10.43 k shares | 0.27 | Common equity | Long | Cayman Islands |
Alkermes plc
|
499.12 k | 17.83 k shares | 0.26 | Common equity | Long | Ireland |
DGX Quest Diagnostics Incorporated | 496.80 k | 3.20 k shares | 0.26 | Common equity | Long | USA |
Sartorius AG (Preference)
|
490.45 k | 1.75 k shares | 0.26 | Common equity | Long | Germany |
BIIB Biogen Inc. | 460.37 k | 2.38 k shares | 0.24 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 459.11 k | 7.82 k shares | 0.24 | Common equity | Long | USA |
Lantheus Holdings, Inc.
|
449.10 k | 4.09 k shares | 0.24 | Common equity | Long | USA |
CNC Centene Corporation | 436.55 k | 5.80 k shares | 0.23 | Common equity | Long | USA |
Zai Lab Ltd.
|
435.97 k | 18.06 k shares | 0.23 | Common equity | Long | Cayman Islands |
PRCT PROCEPT BioRobotics Corporation | 428.00 k | 5.34 k shares | 0.23 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 425.36 k | 13.28 k shares | 0.23 | Common equity | Long | USA |
TXG 10x Genomics, Inc. | 412.81 k | 18.28 k shares | 0.22 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 404.10 k | 5.75 k shares | 0.21 | Common equity | Long | USA |
COR Cencora | 394.79 k | 1.75 k shares | 0.21 | Common equity | Long | USA |
VRNA Verona Pharma plc | 394.15 k | 13.70 k shares | 0.21 | Common equity | Long | UK |
DXCM DexCom, Inc. | 392.72 k | 5.86 k shares | 0.21 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 376.71 k | 15.38 k shares | 0.20 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 372.04 k | 20.17 k shares | 0.20 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 371.18 k | 16.40 k shares | 0.20 | Common equity | Long | UK |
Novocure Ltd.
|
369.16 k | 23.62 k shares | 0.20 | Common equity | Long | Jersey |
DYN Dyne Therapeutics, Inc. | 359.74 k | 10.02 k shares | 0.19 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 354.62 k | 10.43 k shares | 0.19 | Common equity | Long | USA |
Merus NV
|
340.73 k | 6.82 k shares | 0.18 | Common equity | Long | Netherlands |
BTSG BrightSpring Health Services, Inc. Common Stock | 322.40 k | 21.96 k shares | 0.17 | Common equity | Long | USA |
INSP Inspire Medical Systems, Inc. | 315.94 k | 1.50 k shares | 0.17 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 311.75 k | 10.87 k shares | 0.17 | Common equity | Long | USA |
BNTX BioNTech SE | 308.80 k | 2.60 k shares | 0.16 | Common equity | Long | Germany |
BRKR Bruker Corporation | 303.66 k | 4.40 k shares | 0.16 | Common equity | Long | USA |
BLACKROCK LIQUIDITY FEDFUND OPEN-END FUND USD | 300.00 k | 300.00 k principal | 0.16 | Short-term investment vehicle | Long | USA |
GERN Geron Corporation | 299.47 k | 65.96 k shares | 0.16 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 295.54 k | 2.89 k shares | 0.16 | Common equity | Long | USA |
IMNM Immunome, Inc. | 290.43 k | 19.86 k shares | 0.15 | Common equity | Long | USA |
COO The Cooper Companies, Inc. | 286.88 k | 2.60 k shares | 0.15 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 286.53 k | 15.51 k shares | 0.15 | Common equity | Long | USA |
Tempus AI, Inc., Class A
|
276.66 k | 4.89 k shares | 0.15 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 275.81 k | 7.31 k shares | 0.15 | Common equity | Long | USA |
XNCR Xencor, Inc. | 275.63 k | 13.71 k shares | 0.15 | Common equity | Long | USA |
Immatics NV
|
272.04 k | 23.84 k shares | 0.14 | Common equity | Long | Netherlands |
IDYA IDEAYA Biosciences, Inc. | 271.91 k | 8.58 k shares | 0.14 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 269.52 k | 4.68 k shares | 0.14 | Common equity | Long | USA |
RAPP Rapport Therapeutics, Inc. Common Stock | 252.40 k | 12.32 k shares | 0.13 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 240.79 k | 4.77 k shares | 0.13 | Common equity | Long | USA |
INCY Incyte Corporation | 237.96 k | 3.60 k shares | 0.13 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 218.77 k | 27.31 k shares | 0.12 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 214.95 k | 8.73 k shares | 0.11 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 207.42 k | 18.93 k shares | 0.11 | Common equity | Long | USA |
WaVe Life Sciences Ltd.
|
207.09 k | 25.26 k shares | 0.11 | Common equity | Long | Singapore |
IGMS IGM Biosciences, Inc. | 201.18 k | 12.16 k shares | 0.11 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 200.64 k | 26.40 k shares | 0.11 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 199.92 k | 21.29 k shares | 0.11 | Common equity | Long | USA |
MBX MBX Biosciences, Inc. Common Stock | 194.93 k | 7.50 k shares | 0.10 | Common equity | Long | USA |
BCAX Bicara Therapeutics Inc. Common Stock | 189.14 k | 7.43 k shares | 0.10 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 185.44 k | 26.19 k shares | 0.10 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 171.03 k | 61.08 k shares | 0.09 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 169.59 k | 3.24 k shares | 0.09 | Common equity | Long | USA |
ORKA Oruka Therapeutics Inc. | 168.95 k | 6.89 k shares | 0.09 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 166.26 k | 5.77 k shares | 0.09 | Common equity | Long | USA |
Prothena Corp. plc
|
165.88 k | 9.91 k shares | 0.09 | Common equity | Long | Ireland |
SANA Sana Biotechnology, Inc. | 161.22 k | 38.76 k shares | 0.09 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 160.93 k | 15.70 k shares | 0.09 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 158.82 k | 3.23 k shares | 0.08 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 153.83 k | 22.33 k shares | 0.08 | Common equity | Long | USA |
NMRA Neumora Therapeutics, Inc. Common Stock | 151.92 k | 11.50 k shares | 0.08 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 150.75 k | 4.50 k shares | 0.08 | Common equity | Long | USA |
Pharvaris NV
|
136.23 k | 7.36 k shares | 0.07 | Common equity | Long | Netherlands |
LYEL Lyell Immunopharma, Inc. | 129.13 k | 93.57 k shares | 0.07 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 127.87 k | 4.35 k shares | 0.07 | Common equity | Long | USA |
ALHC Alignment Healthcare, Inc. | 127.12 k | 10.76 k shares | 0.07 | Common equity | Long | USA |
ENOV Enovis Corporation | 120.54 k | 2.80 k shares | 0.06 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 118.63 k | 22.38 k shares | 0.06 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 117.93 k | 10.52 k shares | 0.06 | Common equity | Long | USA |
Helix Acquisition Corp. II, Class A
|
116.97 k | 11.19 k shares | 0.06 | Common equity | Long | Cayman Islands |
TARS Tarsus Pharmaceuticals, Inc. | 115.02 k | 3.50 k shares | 0.06 | Common equity | Long | USA |
TRDA Entrada Therapeutics, Inc. | 106.51 k | 6.67 k shares | 0.06 | Common equity | Long | USA |
Sensorion SA
|
106.22 k | 125.89 k shares | 0.06 | Common equity | Long | France |
Akeso, Inc.
|
105.89 k | 12.00 k shares | 0.06 | Common equity | Long | Cayman Islands |
OCUL Ocular Therapeutix, Inc. | 90.48 k | 10.40 k shares | 0.05 | Common equity | Long | USA |
ANNX Annexon, Inc. | 90.10 k | 15.22 k shares | 0.05 | Common equity | Long | USA |
BIOA BioAge Labs, Inc. | 89.90 k | 4.32 k shares | 0.05 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 88.76 k | 11.11 k shares | 0.05 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 82.88 k | 14.17 k shares | 0.04 | Common equity | Long | USA |
APLT Applied Therapeutics, Inc. | 79.90 k | 9.40 k shares | 0.04 | Common equity | Long | USA |
LENZ LENZ Therapeutics, Inc. | 78.22 k | 3.30 k shares | 0.04 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 77.50 k | 1.71 k shares | 0.04 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 74.73 k | 5.37 k shares | 0.04 | Common equity | Long | USA |
GBIO Generation Bio Co. | 74.44 k | 30.14 k shares | 0.04 | Common equity | Long | USA |
Pharming Group NV
|
74.12 k | 88.79 k shares | 0.04 | Common equity | Long | Netherlands |
ANRO Alto Neuroscience, Inc. | 73.11 k | 6.39 k shares | 0.04 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 72.75 k | 5.20 k shares | 0.04 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 70.32 k | 9.74 k shares | 0.04 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 67.73 k | 18.41 k shares | 0.04 | Common equity | Long | USA |
GOSS Gossamer Bio, Inc. | 66.40 k | 67.31 k shares | 0.04 | Common equity | Long | USA |
AURA Aura Biosciences, Inc. | 65.02 k | 7.30 k shares | 0.03 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 63.80 k | 4.40 k shares | 0.03 | Common equity | Long | USA |
CRBP Corbus Pharmaceuticals Holdings, Inc. | 61.89 k | 3.00 k shares | 0.03 | Common equity | Long | USA |
TERN Terns Pharmaceuticals, Inc. | 60.19 k | 7.22 k shares | 0.03 | Common equity | Long | USA |
ALEC Alector, Inc. | 59.90 k | 12.85 k shares | 0.03 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 58.12 k | 16.01 k shares | 0.03 | Common equity | Long | UK |
IMRX Immuneering Corporation | 56.10 k | 22.53 k shares | 0.03 | Common equity | Long | USA |
MGNX MacroGenics, Inc. | 49.02 k | 14.90 k shares | 0.03 | Common equity | Long | USA |
OBIO Orchestra BioMed Holdings, Inc. | 46.50 k | 9.05 k shares | 0.02 | Common equity | Long | USA |
NxStage Medical, Inc. | 43.40 k | 25.53 k shares | 0.02 | Common equity | Long | USA |
Silence Therapeutics plc
|
40.00 k | 2.20 k shares | 0.02 | Common equity | Long | UK |
RGLS Regulus Therapeutics Inc. | 34.85 k | 22.20 k shares | 0.02 | Common equity | Long | USA |
BDTX Black Diamond Therapeutics, Inc. | 33.93 k | 7.80 k shares | 0.02 | Common equity | Long | USA |
CLYM Climb Bio, Inc. | 33.09 k | 6.50 k shares | 0.02 | Common equity | Long | USA |
KYTX Kyverna Therapeutics, Inc. | 32.06 k | 6.56 k shares | 0.02 | Common equity | Long | USA |
WGS GeneDx Holdings Corp. | 31.58 k | 744.00 shares | 0.02 | Common equity | Long | USA |
CABA Cabaletta Bio, Inc. | 30.21 k | 6.40 k shares | 0.02 | Common equity | Long | USA |
ABOS Acumen Pharmaceuticals, Inc. | 23.54 k | 9.49 k shares | 0.01 | Common equity | Long | USA |
PRLD Prelude Therapeutics Incorporated | 22.66 k | 10.95 k shares | 0.01 | Common equity | Long | USA |
CCCC C4 Therapeutics, Inc. | 18.24 k | 3.20 k shares | 0.01 | Common equity | Long | USA |
DNA Ginkgo Bioworks Holdings, Inc. | 10.97 k | 1.35 k shares | 0.01 | Common equity | Long | USA |
RAPT RAPT Therapeutics, Inc. | 5.98 k | 2.97 k shares | 0.00 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 437.78 | 3.13 k shares | 0.00 | DO | N/A | USA |
WGS GeneDx Holdings Corp. | 245.90 | 3.33 k shares | 0.00 | DO | N/A | USA |
SLGCW SomaLogic, Inc. | 0 | 1.42 k shares | 0.00 | DO | N/A | USA |